Literature DB >> 25738138

Will the 40-gene expression classifier predict responders to EGFR targeted chemotherapy for the invasive bladder cancer patients?

Jayoung Kim1, Wun-Jae Kim1.   

Abstract

Entities:  

Year:  2015        PMID： 25738138      PMCID： PMC4322164          DOI： 10.3978/j.issn.2305-5839.2015.01.05

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  9 in total

Review 1.  Bladder cancer in 2012: Challenging current paradigms.

Authors:  Aidan P Noon; James W F Catto
Journal:  Nat Rev Urol       Date:  2013-01-08       Impact factor: 14.432

2.  A four-gene signature predicts disease progression in muscle invasive bladder cancer.

Authors:  Wun-Jae Kim; Seon-Kyu Kim; Pildu Jeong; Seok-Joong Yun; In-Chang Cho; Isaac Yi Kim; Sung-Kwon Moon; Hong-Duck Um; Yung Hyun Choi
Journal:  Mol Med       Date:  2011-02-04       Impact factor: 6.354

3.  Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy.

Authors:  Woonyoung Choi; Sima Porten; Seungchan Kim; Daniel Willis; Elizabeth R Plimack; Jean Hoffman-Censits; Beat Roth; Tiewei Cheng; Mai Tran; I-Ling Lee; Jonathan Melquist; Jolanta Bondaruk; Tadeusz Majewski; Shizhen Zhang; Shanna Pretzsch; Keith Baggerly; Arlene Siefker-Radtke; Bogdan Czerniak; Colin P N Dinney; David J McConkey
Journal:  Cancer Cell       Date:  2014-02-10       Impact factor: 31.743

4.  Molecular subtyping of invasive bladder cancer: time to divide and rule?

Authors:  Carolyn D Hurst; Margaret A Knowles
Journal:  Cancer Cell       Date:  2014-02-10       Impact factor: 31.743

Review 5.  Management of superficial and muscle-invasive urothelial cancers of the bladder.

Authors:  Matthew J Resnick; Jeffrey C Bassett; Peter E Clark
Journal:  Curr Opin Oncol       Date:  2013-05       Impact factor: 3.645

6.  EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype.

Authors:  Sandra Rebouissou; Isabelle Bernard-Pierrot; Aurélien de Reyniès; May-Linda Lepage; Clémentine Krucker; Elodie Chapeaublanc; Aurélie Hérault; Aurélie Kamoun; Aurélie Caillault; Eric Letouzé; Nabila Elarouci; Yann Neuzillet; Yves Denoux; Vincent Molinié; Dimitri Vordos; Agnès Laplanche; Pascale Maillé; Pascale Soyeux; Karina Ofualuka; Fabien Reyal; Anne Biton; Mathilde Sibony; Xavier Paoletti; Jennifer Southgate; Simone Benhamou; Thierry Lebret; Yves Allory; François Radvanyi
Journal:  Sci Transl Med       Date:  2014-07-09       Impact factor: 17.956

Review 7.  New directions for biologic targets in urothelial carcinoma.

Authors:  Suzanne Richter; Srikala S Sridhar
Journal:  Mol Cancer Ther       Date:  2012-05-09       Impact factor: 6.261

8.  Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer.

Authors:  Wun-Jae Kim; Eun-Jung Kim; Seon-Kyu Kim; Yong-June Kim; Yun-Sok Ha; Pildu Jeong; Min-Ju Kim; Seok-Joong Yun; Keon Myung Lee; Sung-Kwon Moon; Sang-Cheol Lee; Eun-Jong Cha; Suk-Chul Bae
Journal:  Mol Cancer       Date:  2010-01-08       Impact factor: 27.401

9.  Comprehensive molecular characterization of urothelial bladder carcinoma.

Authors: 
Journal:  Nature       Date:  2014-01-29       Impact factor: 49.962
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.